(Q33776106)

29 July 2017

title

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study (English)

1 reference

29 July 2017

1 reference

1 reference

1

Pierre Van Damme

1 reference

29 July 2017

5

Robert Booy

1 reference

29 July 2017

Anna Moiseeva

2

1 reference

29 July 2017

Igor Marichev

3

1 reference

29 July 2017

Anne-Diane Kervyn

4

1 reference

29 July 2017

Sherine Kuriyakose

6

1 reference

29 July 2017

Andrew Brockway

7

1 reference

29 July 2017

Su-Peing Ng

8

1 reference

29 July 2017

Maarten Leyssen

9

1 reference

29 July 2017

Jeanne-Marie Jacquet

10

1 reference

29 July 2017

publication date

20 December 2010

1 reference

29 July 2017

published in

BMC Infectious Diseases

1 reference

29 July 2017

volume

10

1 reference

29 July 2017

page(s)

357

1 reference

Creative Commons Attribution 2.0 Generic

29 July 2017

copyright license

start time

1 December 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016379

Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016379

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016379

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016379

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016379

A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-357

Hepatitis B vaccination among adolescents in 3 large health maintenance organizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-357

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-357

A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-357

Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-357

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-357

Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-357

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016379

Decreased immune response to hepatitis B eight years after routine vaccination in Israel

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016379

Predictors of time to completion of the hepatitis B vaccination series among adolescents

30 October 2018

1 reference

12 December 2020

Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years

1 reference

12 December 2020

Global progress toward universal childhood hepatitis B vaccination, 2003

1 reference

12 December 2020

Hepatitis B vaccine completion among adolescents

1 reference

12 December 2020

Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children

1 reference

12 December 2020

Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial

1 reference

12 December 2020

Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults

1 reference

12 December 2020

Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-10-357

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference